Ann: 2021 Annual Report to Shareholders, page-60

Agreed, if one looks logically at the timeline of when the 1st patient cleared the trial, and when multiple ( 2 or more? ) cleared the trial, and locations opened at that time, and the state of SARS-COV-2 & then compare that to the recent timeline of sites open ( the number, quality and location ), and the current state of SARS-COV-2 its only logical to deduce that the numbers of patients completed/enrolled should be closing in on the minimum number of the target or 15.
I'm of the opinion that they'll update us the same way Spikeup has described it. Only question in my mind, will it be 15 patients to wrap it up, or 30, or some number in between? I'm sure Siemens Healthineers will have input on that decision also, as they are partnered for 1/2 of the Dual trial.
Only time will. And exciting time it is, for those with patience.